Aprepitanttilääkitys keskeytettiin haittavaikutusten vuoksi 1, 1 prosentilla aprepitanttihoito - ohjelmaa saaneista potilaista. ###>Aprepitant was discontinued due to adverse reactions in 1.1% of patients treated with the aprepitant regimen compared with 0.5% of patients treated with standard therapy.